Show simple item record

Biološki lekovi: Tri decenije razvoja

dc.creatorSavić, Miroslav
dc.date.accessioned2019-09-02T11:31:31Z
dc.date.available2019-09-02T11:31:31Z
dc.date.issued2012
dc.identifier.issn0004-1963
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/1807
dc.description.abstractAny medicine whose active substance is present in living organisms, or derived from living organisms, may be considered as a biological product. Vaccines, blood derivatives and products, or hormones isolated from animal or human tissues are produced by traditional biotechnological means and have a long history of use as biologies. With introduction of the recombinant human insulin in 1982, there started an era of 'high-tech' biological medicines, also known as biopharmaceuticals. Recombinant proteins, produced by recombinant DNA technology, and monoclonal antibodies, whose development was based on hybridoma technology, comprise the majority of biopharmaceuticals. The necessity of using biological methods for full characterization is considered by the drug regulation authorities as the key property of biologies, related to complexity and heterogeneity of their structure. Hence, classification of a product as a biological can change over time. For example, the full characterization of antibiotics by physical and chemical methods is feasible nowadays, and hence these drugs are not regarded as biologies any more. Paradoxically, it is possible that a synthetic product be regarded as a biological medicine, and this is the case with pegaptanib, a pegylated modified oligonucleotide, classified into biopharmaceuticals. Hence, the need of introducing a category of borderline products into classification of medicines is noticeable; these products possess some properties of conventional chemical medicines, in addition to those of biologies.en
dc.publisherSavez farmaceutskih udruženja Srbije, Beograd
dc.rightsopenAccess
dc.sourceArhiv za farmaciju
dc.subjectBiological methodsen
dc.subjectBiopharmaceuticalsen
dc.subjectBiotechnological medicinesen
dc.titleBiological medicines: Three decades of progressen
dc.titleBiološki lekovi: Tri decenije razvojasr
dc.typearticle
dc.rights.licenseBY-SA
dcterms.abstractСавић, Мирослав; Биолошки лекови: Три деценије развоја; Биолошки лекови: Три деценије развоја;
dc.citation.volume62
dc.citation.issue4
dc.citation.spage352
dc.citation.epage363
dc.citation.other62(4): 352-363
dc.citation.rankM53
dc.identifier.scopus2-s2.0-84869838492
dc.identifier.rcubconv_4859
dc.type.versionpublishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record